Tuberculosis

MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people
Chhattisgarh: Treating tuberculosis in the jungle
Access to medicines: MSF demands Johnson & Johnson reduce price of lifesaving TB drug
Tuberculosis: Promising new tuberculosis drug pretomanid approved, but will it be affordable?
Manipur: Providing patient-centered HIV, TB, and hepatitis care to patients
World Tuberculosis Day: Treating the untreatable
Tuberculosis: Activists for first time challenge TB drug patent in India, in bid to prevent J&J from extending monopoly
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
Tuberculosis: Activists for first time challenge TB drug patent in India, in bid to prevent J&J from extending monopoly
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
Renewed hope- Stories of four patients fighting drug-resistant-TB in Mumbai
MSF: India’s decision to give Pfizer unmerited patent on lifesaving pneumonia vaccine limits access for children globally. Photo: Sandra Smiley/MSF
MSF: India’s decision to give Pfizer unmerited patent on lifesaving pneumonia vaccine limits access for children globally